Literature DB >> 30922694

The Slow-Motion Catastrophe of Antimicrobial Resistance and Practical Interventions for All Prescribers.

Emil P Lesho1, Maryrose Laguio-Vila2.   

Abstract

All medical and surgical specialties depend on the pool of effective antibiotics that continues to evaporate because of the increasing prevalence of drug-resistant bacteria. Antimicrobial-resistant infections kill 700,000 patients every year. By 2050, they are projected to cause 10 million deaths per year at a cumulative global cost of $100 trillion. Professional societies and international health agencies, including the United Nations, have declared escalating antimicrobial resistance as one of the gravest and most urgent threats to global public health and issued calls for action. The propensity of bacteria to mobilize and share genetic resistance determinants across species and genera, record levels of conflict-driven human population displacement, and the dearth of new antibiotics and rapid diagnostic tests, along with climate change and the epidemic of opioid addiction, exacerbate the antimicrobial resistance crisis. The predominant cause of antibiotic resistance is exposure to antibiotics through appropriate and inappropriate use. Mindfulness, nudging by peers, and adjuncts and alternatives to antibiotics, such as phage therapies, microbiome-based therapies, and novel medical informatics applications, could help reduce antibiotic use. This article describes the antimicrobial resistance crisis and highlights points in the continuum of care in which clinicians can readily implement practical, no-cost changes to minimize antibiotic exposure.
Copyright © 2018 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30922694     DOI: 10.1016/j.mayocp.2018.11.005

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  16 in total

1.  Infective endocarditis following invasive dental procedures: IDEA case-crossover study.

Authors:  Martin H Thornhill; Annabel Crum; Saleema Rex; Richard Campbell; Tony Stone; Mike Bradburn; Veronica Fibisan; Mark J Dayer; Bernard D Prendergast; Peter B Lockhart; Larry M Baddour; Jon Nicholl
Journal:  Health Technol Assess       Date:  2022-05       Impact factor: 4.106

2.  The second-hand effects of antibiotics: communicating the public health risks of drug resistance.

Authors:  B J Langford; N Daneman; V Leung; J H C Wu; K Brown; K L Schwartz; G Garber
Journal:  JAC Antimicrob Resist       Date:  2019-11-05

Review 3.  Animal Models of Phage Therapy.

Authors:  Samuel Penziner; Robert T Schooley; David T Pride
Journal:  Front Microbiol       Date:  2021-01-28       Impact factor: 5.640

4.  An Evaluation of Antibiotic Prescribing Practices in a Rural Refugee Settlement District in Uganda.

Authors:  Matua Bonniface; Winnie Nambatya; Kalidi Rajab
Journal:  Antibiotics (Basel)       Date:  2021-02-09

Review 5.  Selenium Nanomaterials to Combat Antimicrobial Resistance.

Authors:  Linh B Truong; David Medina-Cruz; Ebrahim Mostafavi; Navid Rabiee
Journal:  Molecules       Date:  2021-06-12       Impact factor: 4.411

6.  Overdiagnosis and overtreatment of nipple and breast candidiasis: A review of the relationship between diagnoses of mammary candidiasis and Candida albicans in breastfeeding women.

Authors:  Pamela Douglas
Journal:  Womens Health (Lond)       Date:  2021 Jan-Dec

Review 7.  Subtribe Hyptidinae (Lamiaceae): A promising source of bioactive metabolites.

Authors:  Henrique Bridi; Gabriela de Carvalho Meirelles; Gilsane Lino von Poser
Journal:  J Ethnopharmacol       Date:  2020-08-05       Impact factor: 4.360

8.  Nanomaterials arising amid antibiotic resistance.

Authors:  Weiwei Gao; Liangfang Zhang
Journal:  Nat Rev Microbiol       Date:  2021-01       Impact factor: 60.633

9.  Trimethoprim-sulfamethoxazole as de-escalation in ventilator-associated pneumonia: a cohort study subanalysis.

Authors:  Alessio Strazzulla; Maria Concetta Postorino; Tracie Youbong; Maxence Rouyer; Clara Flateau; Catherine Chakvetadze; Astrid de Pontfarcy; Aurelia Pitsch; Sebastien Jochmans; Nabil Belfeki; Mehran Monchi; Sylvain Diamantis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-02-24       Impact factor: 3.267

Review 10.  Revisiting Antibiotic Resistance: Mechanistic Foundations to Evolutionary Outlook.

Authors:  Chowdhury M Hasan; Debprasad Dutta; An N T Nguyen
Journal:  Antibiotics (Basel)       Date:  2021-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.